TGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies

This study tests a new drug called TGRX-814 in patients with certain blood cancers that have come back or stopped responding to prior treatments. The trial explores safe doses and early signs of effectiveness. **You may be eligible if...** - You are 18 or older - You have been diagnosed with non-Hodgkin lymphoma, acute lymphoblastic leukemia, acute myeloid leukemia, or a bone marrow disorder called MDS - You are in adequate health with acceptable blood counts and organ function **You may NOT be eligible if...** - You have active infections or serious uncontrolled medical conditions - You have received certain prior treatments that would interfere with the drug - Your cancer has spread to the brain in an active, uncontrolled way Talk to your doctor to see if this trial is right for you.